We have examined the effects of two types of insulin therapy (continuous i.v. infusion (group A: 1.25 u. h~'J and direct i.v 
There is no consensus on the best method of administering insulin for the management of diabetic patients during surgery. I.v. administration of insulin is nevertheless generally considered by most authors to be the safest method [1] [2] [3] [4] [5] [6] . Opinions differ, however, on the method of use. In particular, the role of direct i.v. bolus administration of large doses of insulin is not clear [7, 8] . This technique is a very simple method not requiring a special delivery system. Walts and co-workers have shown that glycaemic control obtained by this method was better than that obtained by subcutaneous administration of insulin [3] . However, discontinuous administration of large doses of insulin has been criticized by Hirsh and colleagues as being unphysiological [7] . This "roller-coaster" approach to glucose control could lead to unstable glycaemia, resulting in a greater number of cases of hyper-or hypoglycaemia. Similarly, this practice might result in an even greater rate of ketogenesis because insulin concentrations may be extremely small before administration of the second bolus of insulin [7] . Conversely, a regular supply of small doses of insulin, creating stable blood insulin concentrations, could reduce this risk [7, 8] ; however, this technique requires the use of an insulin infusion pump.
The aims of this prospective randomized study were to compare intraoperative control of glycaemia obtained with continuous i.v. infusion and direct i.v. bolus and to verify if administration of large bolus doses of insulin is an unphysiological practice that may result in a greater incidence of ketogenesis.
PATIENTS AND METHODS
This study was conducted in 60 diabetic patients undergoing elective surgery. Thirty-one patients were receiving treatment with insulin (IDDM: insulin-dependent diabetes mellitus) and 29 were taking oral hypoglycaemic agents (NIDDM: noninsulin dependent diabetes mellitus). The study was approved by the Ethics Committee of the University hospital centre and informed consent was obtained from all patients. Patients with diabetic ketoacidosis during the preoperative period and patients with impaired renal function (creatinino 150 umol litre" 1 ) or impaired hepatic function (based on routine liver function tests) were excluded. Insulin and sulphonylurea hypoglycaemics were discontinued the night before surgery, and biguanides 72 h previously. Surgery began before 10:00. Three types of procedure were performed: vitrectomy (n = 21: 12 IDDM, nine NIDDM), orthopaedic surgery («= 20: nine IDDM, 11 NIDDM) and abdominal surgery (n=19: 10 IDDM, nine NIDDM). The seriousness of surgery was graded in the following fashion: minor (vitrectomy), moderately serious (cholecystectomy, appendectomy) or major (bowel resection, hip replacement). The patients fasted from the evening before surgery (fast of 12-14 h). All patients were premedicated with flunitrazepam 1-2 mg orally with the dose dependent on age and weight. All pro-cedures were performed with the patients under general anaesthesia with the same anaesthetic drugs including thiopentone, nitrous oxide, enflurane, fentanyl and vecuronium or pancuronium. Anaesthesia was induced when blood glucose concentration was between 5.5 and 11.1 mmol litre" 1 ; if the concentration was less than 5.5 mmol litre" 1 , the rate of infusion of glucose was increased briefly and if it was greater than 11.1 mmol litre" 1 , additional insulin 5 u. was given as i.v. boluses.
Insulin therapy was started just before induction of anaesthesia. Patients received a short-acting insulin (Actrapid HM, Novo, France) through a separate peripheral cannula and were allocated randomly to two groups: group A (15 IDDM, 15 NIDDM) received insulin 1.25 u. h" 1 in continuous i.v. infusion from an electric syringe (40u./31 ml 0.9% saline solution (1.25 u. = 1 ml)) and group B (16 IDDM, 14 NIDDM) received insulin 10 u. by direct i.v. bolus injection every 2 h, based on Walts's program [3] . The problem of insulin adsorption in the syringe was overcome by using large concentrations of insulin and allowing the first 4 ml of the insulin-containing solution to flush through the apparatus [6] . In both groups, when intraoperative blood glucose exceeded 11.1 mmol litre" 1 , an additional bolus of insulin 5 u. was given, with at least 60 min between two successive administrations. Concurrently, a continuous infusion of 5 % glucose was given at a rate of 125 ml h" 1 (6.25 g h"
1
) via the same cannula. A second cannula was used to infuse other medications or volume expanders (0.9 % NaCl only, because fluids containing glucose and lactate were prohibited). The study began just before induction and ended 2 h after surgery. Capillary concentrations of glucose were measured every 15 min with reagent strips (Dextrostix, Ames, Bayer Diagnostics, France) and an automatic glucose analyser (Glucometer 11, Ames, Miles Inc., U.S.A.) [9] . Two samples with small blood glucose concentrations and two with large concentrations were measured 10 times with the reflectance meter. We found a coefficient of variation less than 5 %. Treatment failure was denned as a blood glucose concentration less than 3.3 mmol litre" 1 or greater than 16.5 mmol litre" 1 .
Plasma ketone bodies (acetoacetate, P-hydroxybutyrate), lactate, pyruvate, insulin, C-peptide and counter-regulatory hormones (catecholamines, cortisol, glucagon, growth hormone) were measured in venous samples (S): just before induction (SI), during surgery (S2: 30 min after the beginning of surgery for cholecystectomy and appendectomy; 60 min for vitrectomy, bowel resection and hip replacement) and immediately after tracheal extubation (S3). All venous blood samples were collected after insertion of a catheter into an antecubital vein from the arm not being used for the infusion. For assay of ketone bodies, blood 5 ml was collected into a heparinized syringe and mixed immediately with ice-cold 10 % perchloric acid 5 ml. The suspension was centrifuged at 10000 £ for 15 min at 4 °C. The supernatant was adjusted to pH 6.0 with cold 69 % potassium carbonate and recentrifuged at 10 000 ^ for 5 min at 4 °C. The final supernatant was used to determine ketone body concentrations. Acetoacetate and P-hydroxybutyrate concentrations were measured spectrophotometrically using methods of Mellanby and Williamson [10] and Williamson and Mellanby [11] , respectively (coefficients of variation (inter-assay) 2.8 and 2.1% and sensitivities 0.005 mmol litre" 1 and 0.01 mmol litre" 1 , respectively). The ratio of P-hydroxybutyrate to acetoacetate concentrations was termed the P-hydroxybutyrate: acetoacetate ratio. For assays of lactate and pyruvate, blood 2 ml was taken and mixed immediately with fluoride/ EDTA solution 80 ul (Test-Combination Pyruvate, Boehringer Mannheim Gm bH Diagnostica, Germany). This was centrifuged at 10000 £ for 5 min and the supernatant collected for the lactate dehydrogenase enzymatic reaction. Lactate and pyruvate concentrations were measured spectrophotometrically with the methods of Noll [12] and Czok and Lamprecht [13] , respectively (coefficient of variation (inter-assay) for both values 2.1%; sensitivities 0.1 mmol litre" 1 and 4.5 umol litre" 1 , respectively). The ratio of lactate to pyruvate concentrations was termed the lactate: pyruvate ratio. Plasma insulin, C-peptide, cortisol, glucagon and growth hormone concentrations were analysed by radioimmunoassay using commercial kits (Insulin Kit Sorin Biomedica, Italy; C-peptide radioimmunoassay kit, CIS bioindustries, France; Cortisol radioimmunoassay kit, Immunotech, France; Glucagon kit, Biodata, Italy; hGH "coatria" BioMerieux, France) (coefficients of variation (interassay) 5.5%, 5.5%, 6.04%, 4.2%, 2.1%, respectively; sensitivities 2.5 uiu ml" 1 , 0.05 nmol litre" 1 , 13 nmol litre" 1 , 4.06 pmol litre" 1 and < 0.2 uiu ml" 1 , respectively). Adrenaline and noradrenaline were measured by high pressure liquid chromatography and electrochemical determination (2% coefficient of variation for concentrations tested (inter-assay) [14] ; sensitivities 0.1 nmol litre" 1 and 0.3 nmol litre" 1 , respectively). At SI, laboratory glucose concentrations were determined by the hexokinaseglucose-6-phosphate dehydrogenase method (DuPont Instruments aca) (1.4% coefficient of variation for concentrations tested (inter-assay)). Haemoglobin A lc (Hb A lc ) was measured by chromatography [15] .
The following variables were analysed: capillary glucose concentrations measured before induction of anaesthesia, every 15 min during anaesthesia and for 2 h after operation; total amount of insulin and number of additional boluses administered; plasma acetoacetate, P-hydroxybutyrate concentrations and P-hydroxybutyrate:acetoacetate ratio at SI, S2, S3; plasma lactate, pyruvate concentrations and lactate:pyruvate ratio at SI, S2, S3; plasma insulin, C-peptide and counter-regulatory hormone concentrations at SI, S2, S3.
Statistical analysis of the difference between SI, S2 and S3 and between capillary glucose concentrations was made using two-way analysis of variance (ANOVA) for repeated measurements. An unpaired two-tailed t test was used to compare values between the two groups. Comparisons in one group between two times were made using a two-tailed t test for paired data. The resulting P values were adjusted by Bonferroni's method. The chi-square test was used for non-continuous variables. (J-Hydroxybutyrate: acetoacetate and lactate: pyruvate ratio comparisons were performed using non-parametric tests. The relationships between capillary and laboratory glucose values were studied at SI by linear regression analysis. Results are expressed as means (SEM). P < 0.05 was considered statistically significant. Statistical analysis was performed using a Macintosh II computer, with the STATVIEW statistical program.
RESULTS
There was no significant difference between the two groups ( of glycaemia determined by Hb A lc , and capillary glucose concentrations measured just before induction of anaesthesia. For five patients (two in group A, three in group B) it was necessary to increase the infusion of glucose just before induction of anaesthesia because blood glucose concentrations were less than 5.5 mmol litre" 1 . Six patients (two in group A, four in group B) received additional insulin 5 u. before induction of anaesthesia because blood glucose concentrations were greater than 11.1 mmol litre" 1 (table II) . There was good correlation between capillary and laboratory glucose concentrations (r = 0.91; P< 0.001; y = 0.87x+1.60). There were no significant differences in blood glucose concentrations achieved by the two types of insulin therapy except at 60 min ( fig. 1 ) (group A = 9.0 (0.5) mmol litre" 1 , group B = 6.5 (0.3) mmol litre" 1 (P < 0.01)), but the time courses for changes in the concentrations were significantly different (P < 0.001) between the groups and there was a significant interaction effect of group x time. In group B, 78.4% of blood glucose concentrations were in the range 6-12 mmol litre" 1 , compared with 83.2% in group A (ns) (fig. 2) .
The total amount of insulin given in group B (25.7 (1.7) u.) was twice that in group A (13.5 (1.8) u.) (P < 0.001). There was no significant difference for within-group comparisons.
episode (2.8 mmol litre" 1 ) occurred in group B 30 min after a 10-u. bolus injection. Eight patients in group A and three in group B received blood products during surgery (red cell transfusion or plasma).
Plasma ketone body concentrations were increased at SI (table III) then decreased progressively during the course of surgery (P < 0.05). There were no significant differences between groups. Plasma B-hydroxybutyrate: acetoacetate ratios decreased at S2 and S3 (no difference between groups) (table  III) . Plasma lactate and pyruvate concentrations increased significantly during surgery (P < 0.01 and P < 0.001, respectively) but there was no significant difference between the two groups. The lactate: pyruvate ratio did not change significantly at any time during the study (table III) .
There were no significant differences between groups for hormonal data except for C-peptide concentrations which decreased significantly during the study in group B (P < 0.01) (table IV) . There was also a significant interaction effect of group against time.
DISCUSSION
During operation, insulin regimens must be kept simple and safe to avoid hypoglycaemia, excessive hyperglycaemia and ketogenesis [7] . Insulin therapy by direct i.v. bolus administration of 10 u. as proposed by Walts and colleagues [3] is a simple method. In this study, the control of glycaemia obtained with this method was similar to that obtained with continuous i.v. infusion of insulin. The occurrence of hypo-or hyperglycaemia and ketone body development were comparable with both methods of insulin therapy.
In the bolus group, we observed fluctuating blood glucose concentrations over a 2-h period, with a maximum effect manifest as a decrease in blood glucose 1 h after the bolus injection of 10 u. Moreover, although fluctuating, blood glucose concentrations remained within a relatively narrow range, close to the margin of safety of 6-12 mmol litre" 1 [8, 16] . With regard to the risk of uncontrolled glycaemia one case of hyperglycaemia was noted with each method and a single episode of hypoglycaemia, detected by glucose measurements every 15 min, occurred in the bolus group. In their study, Walts and colleagues reported an 8% incidence of hyperglycaemia and a 5 % incidence of hypoglycaemia [3] . Other studies using continuous i.v. infusion of insulin have reported similar incidences of hypoglycaemia (5-10%), varying between studies and with the insulin infusion rate [1, 5, 17] .
Taitelman, Reece and Bessman compared regimens using insulin 1 or 2 u. h" 1 [1] . With 1 u. h" 1 , glycaemic control was no better than with insulin s.c, but there were no hypoglycaemic reactions; with 2 u. h" 1 , mean glucose control was better, but hypoglycaemic episodes occurred in some patients. We chose a dose intermediate between these two. The use of a rate close to 1 u. h" 1 minimizes the risk of hypoglycaemia and the use of additional boluses, when blood glucose concentration increased as a result of surgical stress, reduced the incidence of hyperglycaemia.
The decrease in ketone body concentrations was similar with both techniques. In our study, bolus administration of insulin did not appear to precipitate the onset of hyperketonaemia. The preoperative increase in plasma ketone bodies that we noted was a consequence of preoperative fasting and insulin deficiency [18] . Under the influence of a decreased insulin: glucagon ratio, the liver becomes ketogenic and free fatty acids are transferred into the mitochondria where beta-oxidation and subsequent ketone formation occur [19] . Initial increased ketone body concentrations diminish rapidly in response to administration of glucose and insulin, regardless of the insulin therapy used. The reduction in P-hydroxybutyrate concentration was proportionally greater than that in acetoacetate, explaining the reduction in the P-hydroxybutyrate: acetoacetate ratio, and was probably linked to a major increase in P-hydroxybutyrate clearance as a result of the effect of insulin [20] . Plasma lactate and pyruvate concentrations after direct i.v. bolus administration were comparable to plasma concentrations after continuing i.v. insulin therapy. Our data from both groups are in agreement with the usual course for lactate and pyruvate during surgery [21, 22] . The increase in blood lactate and pyruvate concentrations during operation is usually attributed to increased extrahepatic production of lactate, decreased uptake of lactate and inhibition of pyruvate oxidation by catecholamines and cortisol. This phenomenon is increased by insulin resistance [18] , glucose supply and inadequate tissue oxygenation [23] . The lactate: pyruvate concentration ratios were within normal limits for venous blood samples and were not affected by the type of insulin therapy used.
We were unable to demonstrate any statistical differences between the effects of continuous infusion and direct i.v. bolus administration of insulin on concentrations of counter-regulatory hormones. Goldberg and colleagues have studied the effect of continuous infusion of small doses of insulin on counter-regulatory hormones in comparison with s.c. administration of insulin [24] . They concluded that endocrine response to surgery was not different with the two methods of administration of insulin. We also conclude that administration of large doses of insulin, despite fluctuating blood concentrations of glucose, does not modify the hormonal response to surgery, although we found a reduction in plasma Cpeptide concentrations in the direct i.v. bolus group. This decrease in endogenous insulin secretion did not affect glycaemic control, ketone body production or lactate and pyruvate concentrations. If the change was cause by anaesthetic agents, as has been described [25, 26] , one would expect to find it also in the continuous infusion group. As catecholamines inhibit insulin secretion via an alpha-adrenergic mechanism [25] and increase insulin clearance [27] , greater adrenergic stimulation in the bolus group may be postulated to have caused the change in endogenous insulin secretion, but catecholamine concentrations were similar in both groups. Another explanation, which we believe is correct, is a negative feedback effect by exogenous insulin on pancreatic insulin secretion. In some patients, insulin concentrations were measured just after administration of the bolus of insulin, and were nine times greater than those observed with continuous infusion. This inhibitory mechanism, that develops over a few hours, has been described by diabetologists in non-surgical situations when insulin therapy is initiated [28] . While the decrease in endogenous insulin secretion with the bolus technique did not affect the control of glycaemia during surgery, the consequences of inhibition on control after operation are unknown.
